Becton, Dickinson and Co. | BDX - Pre Tax Profit

Stock Price
142.35
Daily Change
-1.12 -0.78%
Monthly
-10.27%
Yearly
-19.60%
Q2 Forecast
140.59

Becton, Dickinson and Co. reported $393M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 442M 1000K Sep/2025
Align Technology USD 148.89M 27.71M Mar/2026
AngioDynamics USD -6.4M 5.03M Sep/2025
Avanos Medical USD 1.2M 2.4M Dec/2025
Baxter International USD -756M 877M Dec/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
Boston Scientific USD 700M 238M Dec/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Danaher USD 1.24B 138M Mar/2026
Dentsply International USD -42M 105M Mar/2026
Dexcom USD 340.7M 40.7M Dec/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 169.23M 25.24M Dec/2025
Insulet USD 113M 27.2M Mar/2026
Integra LifeSciences USD -2.41M 6.72M Mar/2026
Intuitive Surgical USD 955.6M 100.4M Dec/2025
J&J USD 7.82B 2.86B Mar/2026
Masimo USD 71.3M 3.6M Mar/2026
Medtronic USD 2.1B 224M Sep/2025
Solventum Corp USD 332M 179M Dec/2025
Stryker USD 1.7B 676M Dec/2025
Tandem Diabetes Care USD 4.68M 29.82M Dec/2025
Teleflex USD 218.94M 657.52M Dec/2025
Terumo JPY 31.67B 13.71B Mar/2026
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Zimmer Biomet Holdings USD 98M 320.7M Dec/2025